Thu, Mar 5, 2015, 12:02 AM EST - U.S. Markets open in 9 hrs 28 mins


% | $
Quotes you view appear here for quick access.

Titan Pharmaceuticals Inc. Message Board

  • settoplunge settoplunge May 18, 2013 9:16 PM Flag

    ProNeura for Parkinson's

    Another company is developing a two month slow release implant of a generic dopamine agonist to treat Parkinson's.

    Per their 10K: they held a meeting with the FDA and "based on this meeting, we believe that we can submit an NDA under Section 505(b)(2) of the FDCA and that the FDA may require only a single successful pivotal Phase III clinical trial for approval."

    Can Titan run one P3 trial to get their ProNeura implant approved?
    What is Sunil waiting for?
    Titan has $17 million. Why not advance the Parkinson's program?
    He will burn all the cash in a year and shareholders will have nothing to show for it.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.4725+0.0095(+2.05%)Oct 31 2:57 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.